Modulation of NF-κB activity and apoptosis in chronic lymphocytic leukemia B cells

Journal of Immunology

Volumn 164, Issue 4, 2000, Pages 2200-2206

  Furman, Richard R ^a   Asgary, Zahra ^a   Mascarenhas, John O ^a   Liou, Hsiou Chi ^a,b   Schattner, Elaine J ^a,b  

^a Weill Cornell Medical Center   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0034651739     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.4.2200     Document Type: Article

References (43)

1. Kipps, T. J., and D. A. Carson. 1993. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood 81:2475.
2. Caligaris-Cappio, F. 1996. B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood 87:2615.
3. Harris, N. L., E. S. Jaffe, H. Stein, P. M. Banks, J. K, Chan, M. L. Cleary, G. Delsol, C. De Wolf-Peeters, B. Falini, and K. C. Gatter. 1994. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361.
4. Uckun, F. M., K. Gajl-Peczalska, D. E. Myers, W. Jaszcz, S. Haissig, and J. A. Ledbetter. 1990. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood 76:2449.
5. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925.
6. van Kooten, C., and J. Banchereau. 1997. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9:330.
7. Lalmanach-Girard, A. C., T. C. Chiles, D. C. Parker, and T. L. Rothstein. 1993. T cell-dependent induction of NF-κB in B cells. J. Exp. Med. 177:1215.
8. Berberich, I., G. L. Shu, and E. A. Clark. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153:4357.
9. Ledbetter, J. A., G. Shu, M. Gallagher, and E. A. Clark. 1987. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). J. Immunol. 138.-788.
10. Liou, H. C., W. C. Sha, M. L. Scott, and D. Baltimore. 1994. Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14:5349.
11. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. van Kooten, Y. J. Liu. F, Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881.
12. Liu, Y. J., D. E. Joshua, G. T. Williams, C. A. Smith, J. Gordon, and I. C. MacLennan. 1989. Mechanism of antigen-driven selection in germinal centres. Nature 342:929.
13. Banchereau, J., P. de Paoli, A. Valle, E. Garcia, and F. Rousset. 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70.
14. + T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 175:1091.
15. Noelle, R. J., M. Roy, D. M. Shepherd, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89:6550.
16. Trentin, L., R. Zambello, R. Sancetta, M. Facco, A. Cerutti, A. Perin, M. Siviero, U. Basso, M. Bortolin, F. Adami, et al. 1997. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res. 57:4940.
17. Schattner, E. J., J. Mascarenhas, I. Reyfman, M. Koshy, C. Woo, S. M. Friedman, and M. K. Crow. 1998. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. Blood 91:2689.
18. Clodi, K., Z. Asgary, S. Zhao, K. O. Kliche, F. Cabanillas, M. Andreeff, and A. Younes. 1998. Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells. Br. J. Haematol. 103:270.
19. Schattner, E. J. 2000. CD40 ligand in CLL pathogenesis and therapy. Leuk. Lyphoma. In press.
20. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705.
21. Baeuerle, P. A., and D. Baltimore. 1996. NF-κB: ten years after. Cell 87:13.
22. Barnes, P. J., and M. Karin. 1997. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066.
23. Sha, W. C. 1998. Regulation of immune responses by NF-κB/Rel transcription factor. J. Exp. Med. 187:143.
24. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225.
25. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1586.
26. Brockman, J. A., D. C. Scherer, T. A. McKinsey, S. M. Hall, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809.
27. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782.
28. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787.
29. Wang, C. Y., M. W. Mayo, and A. S. Baldwin, Jr. 1996. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784.
30. Wang, C. Y., M. W. Mayo, R. G. Korneluk, D. V. Goeddel, and A. S. Baldwin, Jr. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680.
31. Lee, H. H., H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng. 1999. NF-κB-mediated up-regulation of Bcl-X and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96:9136.
32. - Tcell leukemia subclone with contact-dependent helper function. J. Immunol. 147:3389.
33. Fluckiger, A. C., J. F. Rossi, A. Bussel, P. Bryon, J. Banchereau, and T. Defrance. 1992. Responsiveness of chronic lymphocytic leukemia B cells activated via surface lgs or CD40 to B-cell tropic factors. Blood 80:3173.
34. Chandra, J., J. Gilbreath, E. J. Freireich, K. O. Kliche, M. Andreeff, M. Keating, and D. J. McConkey. 1997. Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes. Blood 90:3673.
35. Mach, F., U. Schonbeck, G. K. Sukhova, T. Bourcier, J. Y. Bonnefoy, J. S. Pober, and P. Libby. 1997. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA 94:1931.
36. Romano, M. F., A. Lamberti, P. Tassone, F. Alfinito, S. Costantini, F. Chiurazzi, T. Defrance, P. Bonelli, F. Tuccillo, M, C. Turco, and S. Venuta. 1998. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood 92:990.
37. Yin, M. J., L. B. Christerson, Y. Yamamoto, Y. T. Kwak, S. Xu, F. Mercurio, M. Barbosa, M. H. Cobb, and R. B. Gaynor. 1998. HTLV-1 Tax protein binds to MEKK1 to stimulate IκB kinase activity and NF-κB activation. Cell 93:875.
38. Liebowitz, D. 1998. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N. Engl. J. Med. 338:1413.
39. Hours, V., E. Dejardin, F. Goujon-Letawe, M. P. Merville, and V. Castronovo. 1994. The NF-κB transcription factor and cancer: high expression of NF-κB-and IκB-related proteins in tumor cell lines. Biochem. Pharmacol. 47:145.
40. Bargou, R. C., F. Emmerich, D. Krappmann, K. Bommert, M. Y. Mapara, W. Arnold, H. D. Royer, E. Grinstein, A. Greiner, C. Scheidereit, and B. Dorken. 1997. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest. 100:2961.
41. Wood, K. M., M. Roff, and R. T. Hay. 1998. Defective IκBα in Hodgkin cell lines with constitutively active NF-κB. Oncogene 16:2131.
42. Chandra, J., I. Niemer, J. Gilbreath, K. O. Kliche, M. Andreeff, E. J. Freireich, M. Keating, and D. J. McConkey. 1998. Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes. Blood 92: 4220.
43. Tallman, M. S., and D. Hakimian. 1995. Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders. Blood 86:2463.